Neuronal K<sup>+</sup>-Cl<sup>-</sup> cotransporter KCC2 as a promising drug target for epilepsy treatment.

Publication Year: 2023

DOI:
10.1038/s41401-023-01149-9

PMCID:
PMC10770335

PMID:
37704745

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"We are very grateful for the financial support from the National Natural Science Foundation of China (Grant Nos.: 82170406, 81970238, and 32111530119), Shanghai Municipal Science and Technology Major Project (Grant No.: 2018SHZDZX01), The Royal Society UK (Grant No.: IEC\NSFC\201094), and The Commonwealth Scholarship Commission UK (Grant No.: NGCA-2020-43)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025